Insider Transactions Reported by 18 Insiders of G1 Therapeutics, Inc.

Location
Research Triangle Park, NC

There are no Buy or Sell transactions made by insiders since 07 Jan 2025

G1 Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mark A. Velleca Director $341,307 08 Aug 2023
Jennifer K. Moses Cfo $170,124 03 Jan 2023
James S. Hanson General Counsel $120,890 03 Jan 2023
Willie A. Deese Director $42,337 23 Jun 2022
SETH RUDNICK Director $28,408 29 Jun 2021
Jacks Lee Director $0 18 Sep 2024
Norman Sharpless Director $0 18 Sep 2024
TERRY L. MURDOCK Chief Operating Officer $0 18 Sep 2024
Mark Avagliano Chief Business Officer $0 18 Sep 2024
W. Umstead John Chief Financial Officer $0 18 Sep 2024
Rajesh Malik Chief Medical Officer $0 18 Sep 2024
Andrew Perry Chief Commercial Officer $0 18 Sep 2024
GLENN P. MUIR Director $0 18 Sep 2024
John E. Bailey President and CEO, Director $0 18 Sep 2024
Alicia Secor Director $0 18 Sep 2024
Cynthia Louise Flowers Director $0 18 Sep 2024
Monica Thomas Chief Legal & People Officer $0 18 Sep 2024
Garry A. Nicholson Director $0 18 Sep 2024

Recent Insider Transactions by Companies or Individuals for G1 Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.